Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers

CompletedOBSERVATIONAL
Enrollment

242

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

November 20, 2017

Study Completion Date

November 20, 2017

Conditions
Preeclampsia
Trial Locations (10)

10032

New York-Presbyterian/Columbia University Medical Center, New York

11355

New York-Presbyterian/Queens, Flushing

11501

Winthrop University Hospital Clinical Trials Center, New York

19102

Drexel Medicine, Philadelphia

19718

Christiana Hospital, Newark

77555

The University of Texas Medical Branch, Galveston

02111

Tufts Medical Center, Boston

08901

Saint Peter's University Hospital, New Brunswick

08854

Rutgers University, Piscataway

08080

Virtua Materna-Fetal Medicine Specialists, Sewell

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Illumina, Inc.

INDUSTRY